GB699812A
(en)
|
1950-11-29 |
1953-11-18 |
British Ind Solvents Ltd |
Manufacture of substituted pyrimidones
|
DE1249281B
(de)
|
1963-05-18 |
|
|
|
DE1670912C3
(de)
|
1967-08-18 |
1981-06-11 |
Bayer Ag, 5090 Leverkusen |
Herbizide Mittel auf Basis von 1,2,4-Triazin-5-onen
|
GB1377642A
(en)
|
1971-01-14 |
1974-12-18 |
Koninklijke Gist Spiritus |
Penicillanic and cephalosporanic acid derivatives
|
US3960949A
(en)
*
|
1971-04-02 |
1976-06-01 |
Schering Aktiengesellschaft |
1,2-Biguanides
|
DE2150686A1
(de)
|
1971-10-12 |
1973-04-19 |
Basf Ag |
6-amino-uracil-5-carbonsaeurethioamide
|
BE792206A
(de)
|
1971-12-02 |
1973-06-01 |
Byk Gulden Lomberg Chem Fab |
|
AU5996573A
(en)
|
1972-09-11 |
1975-03-06 |
Commonwealth Scientific And Industrial Research Organisation |
Pyridinium salts
|
US3823135A
(en)
|
1972-12-26 |
1974-07-09 |
Shell Oil Co |
Pyrimidone herbicides
|
GB1464248A
(en)
|
1973-11-01 |
1977-02-09 |
Ici Ltd |
Substituted triazinediones their preparation and use as herbicides
|
DE2361551A1
(de)
|
1973-12-11 |
1975-06-19 |
Basf Ag |
Wasserloesliche azofarbstoffe
|
DE2500024A1
(de)
|
1975-01-02 |
1976-07-08 |
Basf Ag |
Wasserloesliche azofarbstoffe
|
JPS535180A
(en)
|
1976-07-01 |
1978-01-18 |
Sumitomo Chem Co Ltd |
Preparation of 3,4-dihydro-2 (1h) quinazoline derivatives
|
DE2720085A1
(de)
|
1977-05-05 |
1978-11-16 |
Hoechst Ag |
Pyrimido(6,1-a)isochinolin-2-on- derivate
|
US4494978A
(en)
*
|
1976-12-30 |
1985-01-22 |
Chevron Research Company |
Herbicidal N-(N'-hydrocarbyloxycarbamylalkyl)-2,6-dialkyl-alpha-haloacetanilides
|
CH657851A5
(de)
|
1983-06-28 |
1986-09-30 |
Ciba Geigy Ag |
Chromogene chinazolonverbindungen.
|
AR240698A1
(es)
*
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
US5614492A
(en)
*
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
DE3856378T2
(de)
*
|
1987-09-04 |
2000-05-11 |
Beecham Group Plc |
Substituierte Thiazolidindionderivate
|
US4935493A
(en)
*
|
1987-10-06 |
1990-06-19 |
E. I. Du Pont De Nemours And Company |
Protease inhibitors
|
EP0422011A1
(de)
|
1988-05-05 |
1991-04-17 |
BASF Aktiengesellschaft |
Mittel auf der basis von uracil-derivaten zur wachstumsförderung und fettreduktion bei tieren
|
GB8900382D0
(en)
|
1989-01-09 |
1989-03-08 |
Janssen Pharmaceutica Nv |
2-aminopyrimidinone derivatives
|
US5433955A
(en)
|
1989-01-23 |
1995-07-18 |
Akzo N.V. |
Site specific in vivo activation of therapeutic drugs
|
IE63502B1
(en)
|
1989-04-21 |
1995-05-03 |
Zeneca Ltd |
Aminopyrimidine derivatives useful for treating cardiovascular disorders
|
EP0512042B1
(de)
|
1990-01-24 |
1998-04-08 |
BUCKLEY, Douglas I. |
Glp-1-analoga verwendbar in der diabetesbehandlung
|
CA2075637A1
(en)
|
1990-02-13 |
1991-08-14 |
William J. Greenlee |
Angiotensin ii antagonists incorporating a substituted benzyl element
|
US5814460A
(en)
|
1990-02-14 |
1998-09-29 |
Diatide, Inc. |
Method for generating and screening useful peptides
|
US5366862A
(en)
|
1990-02-14 |
1994-11-22 |
Receptor Laboratories, Inc. |
Method for generating and screening useful peptides
|
EP0442473B1
(de)
|
1990-02-15 |
1998-08-19 |
Takeda Chemical Industries, Ltd. |
Pyrimidindionderivate, deren Herstellung und Verwendung
|
US5462928A
(en)
|
1990-04-14 |
1995-10-31 |
New England Medical Center Hospitals, Inc. |
Inhibitors of dipeptidyl-aminopeptidase type IV
|
DE4110019C2
(de)
|
1991-03-27 |
2000-04-13 |
Merck Patent Gmbh |
Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
|
US5387512A
(en)
*
|
1991-06-07 |
1995-02-07 |
Merck & Co. Inc. |
Preparation of 3-[z-benzoxazol-2-yl)ethyl]-5-(1-hydroxyethyl)-6-methyl-2-(1H)-pyridinone by biotransformation
|
ES2153831T3
(es)
|
1991-10-22 |
2001-03-16 |
New England Medical Center Inc |
Inhibidores de dipeptidil-aminopeptidasa de tipo iv.
|
US6825169B1
(en)
|
1991-10-22 |
2004-11-30 |
Trustees Of Tufts College |
Inhibitors of dipeptidyl-aminopeptidase type IV
|
US5350752A
(en)
|
1991-12-16 |
1994-09-27 |
E. R. Squibb & Sons, Inc. |
Dihydropyrimidine derivatives
|
DE4141788A1
(de)
|
1991-12-18 |
1993-06-24 |
Merck Patent Gmbh |
Imidazopyridine
|
TW229142B
(de)
|
1992-04-15 |
1994-09-01 |
Nissan Detrochem Corp |
|
US5602102A
(en)
|
1992-05-29 |
1997-02-11 |
Board Of Regents, The Univ. Of Tx System |
Dipeptidyl peptidase-I inhibitors and uses thereof
|
DE4305602A1
(de)
|
1992-06-17 |
1993-12-23 |
Merck Patent Gmbh |
Imidazopyridine
|
WO1994003055A1
(en)
|
1992-07-31 |
1994-02-17 |
The Government Of The United States Of America, Asrepresented By The Secretary Of The Department Of Health And Human Services |
Producing increased numbers of hematopoietic cells by administering inhibitors of dipeptidyl peptidase iv
|
EP0587377A3
(en)
|
1992-09-10 |
1994-09-21 |
Lilly Co Eli |
Thiazolidinone derivatives as hypoglycemic agents and for treating alzheimer's disease
|
IL106998A0
(en)
*
|
1992-09-17 |
1993-12-28 |
Univ Florida |
Brain-enhanced delivery of neuroactive peptides by sequential metabolism
|
US5811281A
(en)
|
1993-07-12 |
1998-09-22 |
Cornell Research Foundation, Inc. |
Immortalized intestinal epithelial cell lines
|
IL111785A0
(en)
|
1993-12-03 |
1995-01-24 |
Ferring Bv |
Dp-iv inhibitors and pharmaceutical compositions containing them
|
DE4341453A1
(de)
|
1993-12-06 |
1995-06-08 |
Merck Patent Gmbh |
Imidazopyridine
|
ATE202567T1
(de)
|
1994-03-08 |
2001-07-15 |
Otsuka Pharma Co Ltd |
Phosphorsäurediester-derivate
|
US5580979A
(en)
|
1994-03-15 |
1996-12-03 |
Trustees Of Tufts University |
Phosphotyrosine peptidomimetics for inhibiting SH2 domain interactions
|
US5543396A
(en)
|
1994-04-28 |
1996-08-06 |
Georgia Tech Research Corp. |
Proline phosphonate derivatives
|
EP0764151A2
(de)
|
1994-06-10 |
1997-03-26 |
Universitaire Instelling Antwerpen |
Reinigung von serine-protease und dessen synthetischen inhibitoren
|
EP0765117B1
(de)
|
1994-06-17 |
2004-02-18 |
La Trobe University |
Biologische bekämpfung von insekten
|
US5601986A
(en)
*
|
1994-07-14 |
1997-02-11 |
Amgen Inc. |
Assays and devices for the detection of extrahepatic biliary atresia
|
DE4432860A1
(de)
|
1994-09-15 |
1996-03-21 |
Merck Patent Gmbh |
Imidazopyridine
|
US5512549A
(en)
*
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
CA2190973C
(en)
|
1995-04-13 |
2001-06-19 |
Yasuo Konno |
Novel 4,6-diarylpyrimidine derivatives and salts thereof
|
US5614379A
(en)
*
|
1995-04-26 |
1997-03-25 |
Eli Lilly And Company |
Process for preparing anti-obesity protein
|
JP2002515724A
(ja)
|
1995-06-01 |
2002-05-28 |
ダナ−ファーバー キャンサー インスティテュート インコーポレイテッド |
ヒト血清中に見出されたジペプチジルペプチダーゼiv(cd26)の新規形態、その抗体および利用法
|
US6325989B1
(en)
|
1995-06-01 |
2001-12-04 |
Dana-Farber Cancer Institute, Inc. |
Form of dipeptidylpeptidase IV (CD26) found in human serum
|
DE69612698T2
(de)
|
1995-06-09 |
2001-12-06 |
Hoffmann La Roche |
Pyrimidindion-, Pyrimidintrion-, Triazindion-Derivate als alpha-1-adrenergische Rezeptorantagonisten
|
JPH0928376A
(ja)
|
1995-07-21 |
1997-02-04 |
Ajinomoto Co Inc |
新規ジペプチジルペプチダーゼivとその製造方法
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
US20020006899A1
(en)
|
1998-10-06 |
2002-01-17 |
Pospisilik Andrew J. |
Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
|
JPH09295977A
(ja)
|
1996-04-30 |
1997-11-18 |
Terumo Corp |
ピリドピリミジン誘導体及びそれを含有する医薬組成物
|
US5965532A
(en)
|
1996-06-28 |
1999-10-12 |
Trustees Of Tufts College |
Multivalent compounds for crosslinking receptors and uses thereof
|
CZ298812B6
(cs)
|
1996-07-01 |
2008-02-13 |
Dr. Reddy's Laboratories Limited |
Azolidindionové deriváty, způsob jejich přípravy, farmaceutické kompozice s jejich obsahem a jejich použití v léčbě diabetu a příbuzných nemocí
|
US5885997A
(en)
*
|
1996-07-01 |
1999-03-23 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US6006753A
(en)
|
1996-08-30 |
1999-12-28 |
Eli Lilly And Company |
Use of GLP-1 or analogs to abolish catabolic changes after surgery
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
AU4721897A
(en)
|
1996-10-25 |
1998-05-22 |
Tanabe Seiyaku Co., Ltd. |
Tetrahydroisoquinoline derivatives
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
US6011155A
(en)
*
|
1996-11-07 |
2000-01-04 |
Novartis Ag |
N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
IL130181A0
(en)
|
1996-12-05 |
2000-06-01 |
Amgen Inc |
Substituted pyrimidone and pyridone compounds and methods of use
|
GB9702701D0
(en)
|
1997-02-01 |
1997-04-02 |
Univ Newcastle Ventures Ltd |
Quinazolinone compounds
|
US20030060434A1
(en)
*
|
1997-02-18 |
2003-03-27 |
Loretta Nielsen |
Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
|
US6100234A
(en)
|
1997-05-07 |
2000-08-08 |
Tufts University |
Treatment of HIV
|
DK0981630T3
(da)
|
1997-05-16 |
2009-03-09 |
Novozymes Inc |
Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme
|
EP0897012A1
(de)
|
1997-07-05 |
1999-02-17 |
Societe Des Produits Nestle S.A. |
Klonierung der Prolyl-Dipeptidyl-Peptidase von Aspergillus oryzae
|
US6235493B1
(en)
*
|
1997-08-06 |
2001-05-22 |
The Regents Of The University Of California |
Amino acid substituted-cresyl violet, synthetic fluorogenic substrates for the analysis of agents in individual in vivo cells or tissue
|
IL125950A0
(en)
|
1997-09-05 |
1999-04-11 |
Pfizer Prod Inc |
Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
|
EP1019494B1
(de)
*
|
1997-09-29 |
2007-03-21 |
Point Therapeutics, Inc. |
Stimulierung von hämatopoietischen zellen im vitro
|
AU9602198A
(en)
|
1997-10-06 |
1999-04-27 |
Trustees Of Tufts College |
Cytoplasmic dipeptidylpeptidase iv from human t-cells
|
US6485955B1
(en)
|
1997-10-06 |
2002-11-26 |
The Trustees Of Tufts University |
Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease
|
US6342611B1
(en)
*
|
1997-10-10 |
2002-01-29 |
Cytovia, Inc. |
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
|
WO1999018856A1
(en)
|
1997-10-10 |
1999-04-22 |
Cytovia, Inc. |
Novel fluorescent reporter molecules and their applications including assays for caspases
|
WO1999025719A1
(fr)
*
|
1997-11-18 |
1999-05-27 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
Substance physiologiquement active, la sulphostine, procede de fabrication et utilisation
|
FR2771004B1
(fr)
*
|
1997-11-19 |
2000-02-18 |
Inst Curie |
Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
|
US6534626B1
(en)
|
1997-12-01 |
2003-03-18 |
The United States Of America As Represented By The Department Of Health & Human Services |
Chemokine variants
|
US6380357B2
(en)
*
|
1997-12-16 |
2002-04-30 |
Eli Lilly And Company |
Glucagon-like peptide-1 crystals
|
BR9813608B1
(pt)
*
|
1997-12-16 |
2011-11-01 |
|
célula hospedeira de bacillus transgênica, e, processo para produzir um polipeptìdeo tendo atividade aminopeptidase.
|
EP2433623A1
(de)
|
1998-02-02 |
2012-03-28 |
Trustees Of Tufts College |
Verwendung von Dipetidylpeptidasehemmer zur Regulierung des Glukosemetabolismus
|
JP2002506075A
(ja)
|
1998-03-09 |
2002-02-26 |
フォンダテッヒ・ベネルクス・ナムローゼ・フェンノートシャップ |
セリンペプチダーゼ調節剤
|
US20020061839A1
(en)
*
|
1998-03-09 |
2002-05-23 |
Scharpe Simon Lodewijk |
Serine peptidase modulators
|
AU3357299A
(en)
|
1998-03-20 |
1999-10-11 |
Sloan-Kettering Institute For Cancer Research |
Use of dipeptidyl peptidase (dpp4) for suppressing the malignant phenotype of cancer cells
|
JP2003504301A
(ja)
|
1998-04-01 |
2003-02-04 |
ブリストル−マイヤーズ スクイブ ファーマ カンパニー |
インテグリンアンタゴニスト
|
EP1076655A1
(de)
|
1998-04-08 |
2001-02-21 |
Novartis AG |
N-pyridonyl herbizide
|
FR2777283B1
(fr)
|
1998-04-10 |
2000-11-24 |
Adir |
Nouveaux composes peptidiques analogues du glucagon-peptide- 1 (7-37), leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
DE19823831A1
(de)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
KR100704814B1
(ko)
*
|
1998-06-05 |
2007-04-10 |
포인트 써러퓨틱스, 인크. |
시클릭 보로프롤린 화합물
|
DE19828113A1
(de)
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
|
DE19828114A1
(de)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
US6129911A
(en)
|
1998-07-10 |
2000-10-10 |
Rhode Island Hospital, A Lifespan Partner |
Liver stem cell
|
DE19834591A1
(de)
*
|
1998-07-31 |
2000-02-03 |
Probiodrug Ges Fuer Arzneim |
Verfahren zur Steigerung des Blutglukosespiegels in Säugern
|
EP1932535A3
(de)
|
1998-07-31 |
2008-10-29 |
Novo Nordisk A/S |
Anregung der Beta-Zellbildung
|
CA2339326A1
(en)
|
1998-08-10 |
2000-02-24 |
Josephine Egan |
Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof
|
KR20010079669A
(ko)
|
1998-08-21 |
2001-08-22 |
바바라 피. 월너 |
기질 활성의 조절
|
WO2000015211A2
(en)
|
1998-09-17 |
2000-03-23 |
Akesis Pharmaceuticals, Inc. |
Compositions of chromium or vanadium with antidiabetics for glucose metabolism disorders
|
DE19845153A1
(de)
|
1998-10-01 |
2000-04-06 |
Merck Patent Gmbh |
Imidazo[4,5]-pyridin-4-on-derivate
|
US20030176357A1
(en)
|
1998-10-06 |
2003-09-18 |
Pospisilik Andrew J. |
Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
DE19900471A1
(de)
|
1999-01-08 |
2000-07-13 |
Merck Patent Gmbh |
Imidazo[4,5c]-pyridin-4-on-derivate
|
DE60033857T2
(de)
|
1999-01-22 |
2007-10-25 |
Kirin Beer K.K. |
Derivate des N-((Chinolinyl)oxy)-phenyl)-Harnstoffs und des N-((Chinazolinyl)oxy)-phenyl)-Harnstoffs mit Antitumor Aktivität
|
DE60045030D1
(de)
|
1999-02-10 |
2010-11-11 |
Curis Inc |
Peptid yy (pyy) zur behandlung von glukose stoffwechselkrankheiten
|
AU3960400A
(en)
|
1999-03-05 |
2000-09-28 |
Molteni L. E C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A. |
Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv
|
GB9906715D0
(en)
*
|
1999-03-23 |
1999-05-19 |
Ferring Bv |
Compositions for promoting growth
|
GB9906714D0
(en)
|
1999-03-23 |
1999-05-19 |
Ferring Bv |
Compositions for improving fertility
|
WO2000057721A2
(en)
|
1999-03-26 |
2000-10-05 |
Akesis Pharmaceuticals, Inc. |
Edible solids for treatment of glucose metabolism disorders
|
US6548529B1
(en)
|
1999-04-05 |
2003-04-15 |
Bristol-Myers Squibb Company |
Heterocyclic containing biphenyl aP2 inhibitors and method
|
EP1171438A1
(de)
|
1999-04-20 |
2002-01-16 |
Novo Nordisk A/S |
Verbindungen, ihre herstellung und ihre verwendung
|
WO2000069911A1
(en)
*
|
1999-05-17 |
2000-11-23 |
Conjuchem, Inc. |
Long lasting insulinotropic peptides
|
DE19926233C1
(de)
|
1999-06-10 |
2000-10-19 |
Probiodrug Ges Fuer Arzneim |
Verfahren zur Herstellung von Thiazolidin
|
US6107317A
(en)
|
1999-06-24 |
2000-08-22 |
Novartis Ag |
N-(substituted glycyl)-thiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
US6172081B1
(en)
*
|
1999-06-24 |
2001-01-09 |
Novartis Ag |
Tetrahydroisoquinoline 3-carboxamide derivatives
|
US6110949A
(en)
|
1999-06-24 |
2000-08-29 |
Novartis Ag |
N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
US6528486B1
(en)
*
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
US6617340B1
(en)
|
1999-07-29 |
2003-09-09 |
Novartis Ag |
N-(substituted glycyl)-pyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
DE19940130A1
(de)
*
|
1999-08-24 |
2001-03-01 |
Probiodrug Ges Fuer Arzneim |
Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
|
US6881564B1
(en)
|
1999-09-10 |
2005-04-19 |
The University Of Sydney |
Dipeptidyl peptidases
|
US6559188B1
(en)
*
|
1999-09-17 |
2003-05-06 |
Novartis Ag |
Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
|
US6414002B1
(en)
*
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
KR20020047185A
(ko)
|
1999-09-28 |
2002-06-21 |
플레믹 크리스티안 |
퀴나졸리논
|
US6447772B1
(en)
|
1999-10-01 |
2002-09-10 |
Klaire Laboratories, Inc. |
Compositions and methods relating to reduction of symptoms of autism
|
US6251391B1
(en)
*
|
1999-10-01 |
2001-06-26 |
Klaire Laboratories, Inc. |
Compositions containing dipepitidyl peptidase IV and tyrosinase or phenylalaninase for reducing opioid-related symptons
|
AU7559900A
(en)
|
1999-10-08 |
2001-04-23 |
Meiji Seika Kaisha Ltd. |
M-substituted benzoic acid derivatives exhibiting integrinalphavbeta3 antagonism
|
US6261794B1
(en)
|
1999-10-14 |
2001-07-17 |
Saint Louis University |
Methods for identifying inhibitors of methionine aminopeptidases
|
US7230000B1
(en)
|
1999-10-27 |
2007-06-12 |
Cytokinetics, Incorporated |
Methods and compositions utilizing quinazolinones
|
US20040152745A1
(en)
|
1999-11-12 |
2004-08-05 |
Guilford Pharmaceuticals, Inc. |
Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors
|
JP2003535034A
(ja)
|
1999-11-12 |
2003-11-25 |
ギルフォード ファーマシューティカルズ インコーポレイテッド |
ジペプチジルペプチダーゼiv阻害剤並びにジペプチジルペプチダーゼiv阻害剤の製造及び使用法
|
GB9928330D0
(en)
|
1999-11-30 |
2000-01-26 |
Ferring Bv |
Novel antidiabetic agents
|
US20030040478A1
(en)
*
|
1999-12-08 |
2003-02-27 |
Drucker Daniel J |
Chemotherapy treatment
|
US6380398B2
(en)
|
2000-01-04 |
2002-04-30 |
Novo Nordisk A/S |
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
ES2436610T3
(es)
|
2000-01-21 |
2014-01-03 |
Novartis Ag |
Combinaciones que contienen inhibidores de la dipeptidilpeptidasa-IV y agentes antidiabéticos
|
JP2003520849A
(ja)
|
2000-01-24 |
2003-07-08 |
ノボ ノルディスク アクティーゼルスカブ |
酵素dpp−ivの阻害剤であるn−置換2−シアノピロールおよび−ピロリン
|
EP1255738B1
(de)
|
2000-01-25 |
2012-03-07 |
Neurocrine Biosciences, Inc. |
Gonadotropin freisetzende hormon rezeptor antagonisten und ihre verwandten verfahren
|
AU2001232735A1
(en)
*
|
2000-01-27 |
2001-08-07 |
Eli Lilly And Company |
Process for solubilizing glucagon-like peptide 1 compounds
|
US6569901B2
(en)
|
2000-01-28 |
2003-05-27 |
Novo Nordisk A/S |
Alkynyl-substituted propionic acid derivatives, their preparation and use
|
US7217722B2
(en)
|
2000-02-01 |
2007-05-15 |
Kirin Beer Kabushiki Kaisha |
Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
|
AU2001233622A1
(en)
|
2000-02-25 |
2001-09-03 |
Novo-Nordisk A/S |
Inhibition of beta cell degeneration
|
US6395767B2
(en)
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
US6448045B1
(en)
|
2000-03-10 |
2002-09-10 |
The Regents Of The University Of California |
Inducing insulin gene expression in pancreas cells expressing recombinant PDX-1
|
US6608038B2
(en)
|
2000-03-15 |
2003-08-19 |
Novartis Ag |
Methods and compositions for treatment of diabetes and related conditions via gene therapy
|
EP1136482A1
(de)
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
2-Amino-3-(alkyl)-pyrimidonderivate als GSK3beta-Hemmer
|
US6555519B2
(en)
*
|
2000-03-30 |
2003-04-29 |
Bristol-Myers Squibb Company |
O-glucosylated benzamide SGLT2 inhibitors and method
|
CZ20023234A3
(cs)
*
|
2000-03-31 |
2003-01-15 |
Probiodrug Ag |
Léčivo proti diabetu
|
US6573096B1
(en)
|
2000-04-01 |
2003-06-03 |
The Research Foundation At State University Of New York |
Compositions and methods for inhibition of cancer invasion and angiogenesis
|
US6545170B2
(en)
*
|
2000-04-13 |
2003-04-08 |
Pharmacia Corporation |
2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
|
EP1288216A1
(de)
|
2000-04-18 |
2003-03-05 |
Sumitomo Pharmaceuticals Company, Limited |
Tricyclische chinazolindione
|
DK1939203T3
(en)
|
2000-04-25 |
2015-02-23 |
Icos Corp |
INHIBITORS OF HUMAN phosphatidyl-inositol 3-kinase DELTA ISOFORM
|
GB0010188D0
(en)
*
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
GB0010183D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
DE10025464A1
(de)
|
2000-05-23 |
2001-12-06 |
Inst Medizintechnologie Magdeb |
Kombinierte Verwendung von Enzyminhibitoren zur Therapie von Autoimmunerkrankungen, bei Transplantationen und Tumorerkrankungen sowie Kombinationen von Enzyminhibitoren umfassende pharmazeutische Zubereitungen
|
US6783757B2
(en)
*
|
2000-06-01 |
2004-08-31 |
Kirkman Group, Inc. |
Composition and method for increasing exorphin catabolism to treat autism
|
WO2001094597A1
(en)
|
2000-06-09 |
2001-12-13 |
Prozymex A/S |
Purified proenzyme of dipeptidyl peptidase i (pro-dppi)
|
US6432969B1
(en)
|
2000-06-13 |
2002-08-13 |
Novartis Ag |
N-(substituted glycyl)-2 cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
TW583185B
(en)
|
2000-06-13 |
2004-04-11 |
Novartis Ag |
N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same
|
US6620821B2
(en)
|
2000-06-15 |
2003-09-16 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
US6627636B2
(en)
|
2000-06-15 |
2003-09-30 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
US7078397B2
(en)
|
2000-06-19 |
2006-07-18 |
Smithkline Beecham Corporation |
Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
|
GB0014969D0
(en)
|
2000-06-19 |
2000-08-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
JP2004502690A
(ja)
|
2000-07-04 |
2004-01-29 |
ノボ ノルディスク アクティーゼルスカブ |
酵素dpp−ivのインヒビターである複素環式化合物
|
WO2002004610A2
(en)
|
2000-07-10 |
2002-01-17 |
Bayer Aktiengesellschaft |
Regulation of human dipeptidyl-peptidase iv-like enzyme
|
TW535080B
(en)
|
2000-07-24 |
2003-06-01 |
Ten Square Co Ltd |
Method and apparatus for optimal fitting activities into customer idle time
|
JP2002042960A
(ja)
*
|
2000-07-25 |
2002-02-08 |
Yazaki Corp |
コネクタ支持機構
|
US6495544B2
(en)
|
2000-08-01 |
2002-12-17 |
Pharmacia Corporation |
Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase
|
BR0112857A
(pt)
|
2000-08-04 |
2005-02-09 |
Warner Lambert Co |
Compostos 2-(4-piridil)amino-6-dialcoxifenil-pirido-[2,3-d]pirimidin- 7-onas
|
AU7775401A
(en)
|
2000-08-10 |
2002-02-25 |
Welfide Corp |
Proline derivatives and use thereof as drugs
|
US20020165237A1
(en)
|
2000-08-11 |
2002-11-07 |
Fryburg David Albert |
Treatment of the insulin resistance syndrome
|
US20020037829A1
(en)
*
|
2000-08-23 |
2002-03-28 |
Aronson Peter S. |
Use of DPPIV inhibitors as diuretic and anti-hypertensive agents
|
US6900226B2
(en)
|
2000-09-06 |
2005-05-31 |
Hoffman-La Roche Inc. |
Neuropeptide Y antagonists
|
DK1317555T3
(da)
|
2000-09-08 |
2008-03-25 |
Prozymex As |
Dipeptidylpeptidase i krystalstruktur og anvendelser heraf
|
JP2004513090A
(ja)
|
2000-09-27 |
2004-04-30 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病及び脂質異常症の治療のためのベンゾピランカルボン酸誘導体
|
US20020064736A1
(en)
|
2000-09-27 |
2002-05-30 |
Fuji Photo Film Co., Ltd. |
Dye-forming coupler, silver halide photographic light-sensitive material, and method for producing an azomethine dye
|
GB0023983D0
(en)
|
2000-09-29 |
2000-11-15 |
Prolifix Ltd |
Therapeutic compounds
|
SE0003599D0
(sv)
|
2000-10-05 |
2000-10-05 |
Thomas Johansson |
Anordning för fuktabsorption
|
WO2002030891A1
(fr)
*
|
2000-10-06 |
2002-04-18 |
Tanabe Seiyaku Co., Ltd. |
Composes aliphatiques azotes a noyau a cinq elements
|
CN100354417C
(zh)
|
2000-10-12 |
2007-12-12 |
凡林有限公司 |
与dppiv相关的新丝氨酸蛋白酶基因
|
CN1471392A
(zh)
|
2000-10-27 |
2004-01-28 |
ǰ������ҩ��ɷ�����˾ |
用于治疗神经性及神经心理性疾患的方法
|
AUPR107800A0
(en)
|
2000-10-27 |
2000-11-23 |
University Of Sydney, The |
Peptide and nucleic acid molecule ii
|
JP2004518718A
(ja)
*
|
2000-10-30 |
2004-06-24 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
抗糖尿病薬および抗痙攣薬を含んで成る併用療法
|
US6586198B2
(en)
|
2000-10-31 |
2003-07-01 |
Vanderbilt University |
Method of identifying susceptibility to angiotensin converting enzyme inhibto- and vasopeptidase-inhibitor-associated angioedema
|
CA2427610A1
(en)
|
2000-10-31 |
2002-08-08 |
Merck & Co., Inc. |
Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
|
WO2002038742A2
(en)
|
2000-11-08 |
2002-05-16 |
The University Of Georgia Research Foundation, Inc. |
Dipeptidylpeptidases and methods of use
|
US20020155565A1
(en)
|
2000-11-10 |
2002-10-24 |
Pilar Garin-Chesa |
FAP-activated anti-tumor compounds
|
TWI243162B
(en)
*
|
2000-11-10 |
2005-11-11 |
Taisho Pharmaceutical Co Ltd |
Cyanopyrrolidine derivatives
|
US20030055052A1
(en)
*
|
2000-11-10 |
2003-03-20 |
Stefan Peters |
FAP-activated anti-tumor compounds
|
US20030203946A1
(en)
|
2000-11-17 |
2003-10-30 |
Carsten Behrens |
Glucagon antagonists/inverse agonists
|
EP1343763A1
(de)
*
|
2000-11-20 |
2003-09-17 |
Bristol-Myers Squibb Company |
Pyrodon-derivate als ap2 inhibitoren
|
KR100883184B1
(ko)
|
2000-12-11 |
2009-02-12 |
암젠 인코포레이션 |
Cxcr3 길항제
|
CA2433090A1
(en)
|
2000-12-27 |
2002-07-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Dipeptidyl peptidase iv inhibitor
|
CA2436724C
(en)
|
2001-01-02 |
2010-03-16 |
Siegfried Ansorge |
Use of inhibitors of dipeptidyl peptidase iv (dp iv) in combination with inhibitors of alanyl-aminopeptidase (apn)
|
DE10100053A1
(de)
|
2001-01-02 |
2002-08-22 |
Keyneurotek Ag I G |
Verwendung von Enzyminhibitoren der Dipeptidylpeptidase IV sowie der Aminopeptidase N und pharmazeutischen Zubereitungen daraus zur Prävention und/oder Therapie Ischämie-bedingter akuter und chronischer neurodegenerativer Prozesse und Erkrankungen
|
WO2002059301A1
(en)
|
2001-01-27 |
2002-08-01 |
K.U. Leuven Research And Development |
Chemokines
|
US7034039B2
(en)
|
2001-02-02 |
2006-04-25 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compounds
|
TWI255817B
(en)
|
2001-02-14 |
2006-06-01 |
Kissei Pharmaceutical |
Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
|
WO2002066627A1
(en)
|
2001-02-16 |
2002-08-29 |
Bayer Aktiengesellschaft |
Regulation of human dipeptidyl peptidase 8
|
ATE353900T1
(de)
*
|
2001-02-24 |
2007-03-15 |
Boehringer Ingelheim Pharma |
Xanthinderivate, deren herstellung und deren verwendung als arzneimittel
|
US6337069B1
(en)
*
|
2001-02-28 |
2002-01-08 |
B.M.R.A. Corporation B.V. |
Method of treating rhinitis or sinusitis by intranasally administering a peptidase
|
JP4178816B2
(ja)
|
2001-03-15 |
2008-11-12 |
田辺三菱製薬株式会社 |
医薬組成物
|
EP1372650B1
(de)
*
|
2001-03-19 |
2008-11-19 |
Novartis AG |
Kombinationen, ein antidiarrhoikum und epothilon oder ein epothilonderivat enthaltend
|
DE60226723D1
(de)
|
2001-03-27 |
2008-07-03 |
Merck & Co Inc |
Dipeptidylpeptidase-hemmer für die behandlung oder prävention von diabetes
|
FR2822826B1
(fr)
*
|
2001-03-28 |
2003-05-09 |
Servier Lab |
Nouveaux derives sulfonyles d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
DE10115921A1
(de)
|
2001-03-30 |
2002-10-02 |
Boehringer Ingelheim Pharma |
Verfahren zur Herstellung von 4,6-Diaminopyrimido[5,4-d]pyrimidinen
|
US6890905B2
(en)
|
2001-04-02 |
2005-05-10 |
Prosidion Limited |
Methods for improving islet signaling in diabetes mellitus and for its prevention
|
GB0109146D0
(en)
|
2001-04-11 |
2001-05-30 |
Ferring Bv |
Treatment of type 2 diabetes
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
PE20021080A1
(es)
|
2001-04-12 |
2003-02-12 |
Boehringer Ingelheim Int |
Un anticuerpo especifico fapo bibh1 en el tratamiento del cancer
|
JP2004533449A
(ja)
|
2001-05-11 |
2004-11-04 |
ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システム |
Cd26を発現している細胞に関連する疾患の治療としての抗cd26モノクローナル抗体
|
FR2824825B1
(fr)
*
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US20030060494A1
(en)
|
2001-05-18 |
2003-03-27 |
Nobuyuki Yasuda |
Pharmaceutical use of N-carbamoylazole derivatives
|
IL143366A0
(en)
|
2001-05-24 |
2002-04-21 |
Harasit Medical Res Services & |
Treatment of renal fibrosis
|
US7105556B2
(en)
*
|
2001-05-30 |
2006-09-12 |
Bristol-Myers Squibb Company |
Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
|
US6794379B2
(en)
*
|
2001-06-06 |
2004-09-21 |
Tularik Inc. |
CXCR3 antagonists
|
WO2003000181A2
(en)
|
2001-06-20 |
2003-01-03 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
JP2004535433A
(ja)
|
2001-06-20 |
2004-11-25 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病治療用のジペプチジルペプチダーゼ阻害薬
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
DE60221983T2
(de)
|
2001-06-27 |
2008-05-15 |
Smithkline Beecham Corp. |
Fluorpyrrolidine als dipeptidyl-peptidase inhibitoren
|
DE10154689A1
(de)
|
2001-11-09 |
2003-05-22 |
Probiodrug Ag |
Substituierte Aminoketonverbindungen
|
AU2002321135B2
(en)
|
2001-06-27 |
2007-11-08 |
Probiodrug Ag |
Dipepitdyl peptidase IV inhibitors and their uses as anti-cancer agents
|
EP1399420B1
(de)
|
2001-06-27 |
2007-12-05 |
SmithKline Beecham Corporation |
Pyrrolidine als dipeptidyl peptidase inhibitoren
|
DE60222667T2
(de)
|
2001-06-27 |
2008-07-17 |
Smithkline Beecham Corp. |
Fluorpyrrolidine als dipeptidylpeptidaseinhibitoren
|
US7368421B2
(en)
|
2001-06-27 |
2008-05-06 |
Probiodrug Ag |
Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
|
US20030135023A1
(en)
|
2001-06-27 |
2003-07-17 |
Hans-Ulrich Demuth |
Peptide structures useful for competitive modulation of dipeptidyl peptidase IV catalysis
|
DE10150203A1
(de)
|
2001-10-12 |
2003-04-17 |
Probiodrug Ag |
Peptidylketone als Inhibitoren der DPIV
|
US20030130199A1
(en)
|
2001-06-27 |
2003-07-10 |
Von Hoersten Stephan |
Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
|
ATE388951T1
(de)
|
2001-07-03 |
2008-03-15 |
Novo Nordisk As |
Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
|
US6869947B2
(en)
|
2001-07-03 |
2005-03-22 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
AU2002322585A1
(en)
|
2001-07-20 |
2003-03-03 |
Adipogenix, Inc. |
Fat accumulation-modulating compounds
|
TW569108B
(en)
*
|
2001-07-24 |
2004-01-01 |
United Microelectronics Corp |
Method of combining power lines to form standard logic unit database
|
AU2002330672A1
(en)
|
2001-07-25 |
2003-02-17 |
Genset S.A. |
Gmg-1 polynucleotides and polypeptides and uses thereof
|
IL159872A0
(en)
|
2001-07-26 |
2004-06-20 |
Genset Sa |
Gmg-2 polypeptides and their use
|
EP1414785A1
(de)
|
2001-07-30 |
2004-05-06 |
Novo Nordisk A/S |
Neue vinyl-n-(2-benzoylphenyl)-l-tyrosinderivate und deren verwendung als antidiabetika usw.
|
KR20040019087A
(ko)
|
2001-07-30 |
2004-03-04 |
노보 노르디스크 에이/에스 |
신규 비닐 카르복실산 유도체 및 항당뇨제 등으로서그들의 사용
|
ATE408414T1
(de)
|
2001-07-31 |
2008-10-15 |
Us Gov Health & Human Serv |
Glp 1 exendin 4 peptidanaloga und deren verwendungen
|
EP1572885A2
(de)
|
2001-08-08 |
2005-09-14 |
Genzyme Corporation |
Verfahren zur behandlung von diabetes und anderer blutzuckerstörungen
|
US7279550B2
(en)
|
2001-08-13 |
2007-10-09 |
Probiodrug Ag |
Irreversible cysteine protease inhibitors of legumain
|
EP1285922A1
(de)
|
2001-08-13 |
2003-02-26 |
Warner-Lambert Company |
1-alkyl oder 1-cycloalkyltriazolo[4,3-a]chinazolin-5-one als phosphodiesterase Inhibitoren
|
JP2003128551A
(ja)
|
2001-08-15 |
2003-05-08 |
Sankyo Co Ltd |
新規抗糖尿病医薬組成物
|
US6844316B2
(en)
|
2001-09-06 |
2005-01-18 |
Probiodrug Ag |
Inhibitors of dipeptidyl peptidase I
|
DE10143840A1
(de)
|
2001-09-06 |
2003-03-27 |
Probiodrug Ag |
Neue Inhibitoren der Dipeptidylpeptidase I
|
US20030186963A1
(en)
|
2001-09-14 |
2003-10-02 |
Dorwald Florencio Zaragoza |
Substituted piperidines
|
US6673829B2
(en)
*
|
2001-09-14 |
2004-01-06 |
Novo Nordisk A/S |
Aminoazetidine,-pyrrolidine and -piperidine derivatives
|
US20040259883A1
(en)
|
2001-09-14 |
2004-12-23 |
Hiroshi Sakashita |
Thiazolidine derivative and medicinal use thereof
|
WO2003024965A2
(en)
|
2001-09-19 |
2003-03-27 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
|
CN104744461A
(zh)
|
2001-09-21 |
2015-07-01 |
百时美施贵宝公司 |
含有内酰胺的化合物及其衍生物作为Xa因子的抑制剂
|
DE60208051T2
(de)
|
2001-09-21 |
2006-06-22 |
Sanofi-Aventis |
3-substituierte-4-pyrimidonderivate
|
EA007576B1
(ru)
|
2001-09-21 |
2006-12-29 |
Мицубиси Фарма Корпорейшн |
Производные 3-замещенных 4-пиримидонов
|
US7019010B2
(en)
|
2001-09-27 |
2006-03-28 |
Novertis Ag |
Combinations
|
ATE447565T1
(de)
*
|
2001-10-01 |
2009-11-15 |
Bristol Myers Squibb Co |
Spiro-hydantoin-verbindungen, die sich als entzündungshemmende mittel eignen
|
WO2003030946A1
(en)
|
2001-10-09 |
2003-04-17 |
Novartis Ag |
Regulation of insulin production
|
US7064135B2
(en)
|
2001-10-12 |
2006-06-20 |
Novo Nordisk Inc. |
Substituted piperidines
|
BR0213377A
(pt)
|
2001-10-18 |
2006-05-23 |
Bristol Myers Squibb Co |
mìmico de peptìdeo semelhante ao glucagon 1 humano e seu uso no tratamento de diabetes e condições relacionadas
|
TWI301834B
(en)
|
2001-10-22 |
2008-10-11 |
Eisai R&D Man Co Ltd |
Pyrimidone compound and pharmaceutical composition including the same
|
GB0125445D0
(en)
|
2001-10-23 |
2001-12-12 |
Ferring Bv |
Protease Inhibitors
|
GB0125446D0
(en)
|
2001-10-23 |
2001-12-12 |
Ferring Bv |
Novel anti-diabetic agents
|
US6861440B2
(en)
*
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
EP1470246A2
(de)
|
2001-10-31 |
2004-10-27 |
Novartis AG |
Methoden zur behandlung von diabetes und ähnlicher zustände basierend auf polymorphismen des tcf1-gens
|
WO2003040114A1
(en)
|
2001-11-06 |
2003-05-15 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
US20030125304A1
(en)
|
2001-11-09 |
2003-07-03 |
Hans-Ulrich Demuth |
Substituted amino ketone compounds
|
US20030089935A1
(en)
*
|
2001-11-13 |
2003-05-15 |
Macronix International Co., Ltd. |
Non-volatile semiconductor memory device with multi-layer gate insulating structure
|
EP2316470A3
(de)
|
2001-11-26 |
2011-08-24 |
Trustees Of Tufts College |
Peptidomimetikuminhibitoren von post-Prolin-spaltenden Enzymen
|
EP1448526B1
(de)
|
2001-11-26 |
2009-10-21 |
Schering Corporation |
Piperidin mch antagonisten und ihre verwendung in der behandlung von obesität und störungen des zentralnervensystems
|
EP2769715A3
(de)
|
2001-11-26 |
2014-09-17 |
Trustees Of Tufts College |
Verfahren zur Behandlung von Autoimmunkrankheiten und damit zusammenhängende Reagenzien
|
WO2003048081A2
(en)
|
2001-12-04 |
2003-06-12 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
GB0129988D0
(en)
|
2001-12-14 |
2002-02-06 |
Ferring Bv |
Imidazolidineacetic acid derivatives
|
JP2005518376A
(ja)
|
2001-12-14 |
2005-06-23 |
ノボ ノルディスク アクティーゼルスカブ |
化合物およびホルモン感受性リパーゼの活性を低下させるためのその使用
|
SE0104340D0
(sv)
|
2001-12-20 |
2001-12-20 |
Astrazeneca Ab |
New compounds
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
AU2002351748B2
(en)
|
2001-12-21 |
2009-07-09 |
Novo Nordisk A/S |
Amide derivatives as GK activators
|
WO2003057144A2
(en)
|
2001-12-26 |
2003-07-17 |
Guilford Pharmaceuticals |
Change inhibitors of dipeptidyl peptidase iv
|
US6727261B2
(en)
*
|
2001-12-27 |
2004-04-27 |
Hoffman-La Roche Inc. |
Pyrido[2,1-A]Isoquinoline derivatives
|
ES2280596T3
(es)
|
2001-12-29 |
2007-09-16 |
Novo Nordisk A/S |
Uso combinado de un compuesto de glp-1 y un inhibidor de una aldosa reductasa.
|
ATE409466T1
(de)
|
2002-01-11 |
2008-10-15 |
Novo Nordisk As |
Verfahren und zusammensetzung zur behandlung von diabetes, hypertonie, chronischer herzinsuffizienz und mit flüssigkeitsretention einhergehenden zuständen
|
AU2003207717B9
(en)
|
2002-02-01 |
2009-05-07 |
Merck & Co., Inc. |
11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
|
AU2003218969A1
(en)
|
2002-02-01 |
2003-09-02 |
Probiodrug Ag |
Modulation of t lymphocytes using dp iv inhibitors
|
US7101898B2
(en)
|
2002-02-01 |
2006-09-05 |
Novo Nordisk A/S |
Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
|
JP4359146B2
(ja)
*
|
2002-02-13 |
2009-11-04 |
エフ.ホフマン−ラ ロシュ アーゲー |
新規なピリジン−およびピリミジン−誘導体
|
ATE309988T1
(de)
|
2002-02-13 |
2005-12-15 |
Hoffmann La Roche |
Neue pyridin- und quinolin-derivate
|
ES2246481T3
(es)
|
2002-02-27 |
2006-02-16 |
Pfizer Products Inc. |
Inhibidores de la acc.
|
HUP0600057A2
(en)
|
2002-02-28 |
2006-05-29 |
Prosidion Ltd |
Glutaminyl based dpiv inhibitors, pharmaceutical compositions comprising thereof and their use
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
DE60336901D1
(de)
|
2002-03-07 |
2011-06-09 |
X Ceptor Therapeutics Inc |
Chinazolinon modulatoren von nukleinrezeptoren
|
CN1274668C
(zh)
|
2002-03-11 |
2006-09-13 |
诺瓦提斯公司 |
那格列奈的盐
|
CN1646500A
(zh)
|
2002-03-13 |
2005-07-27 |
欧洲凯尔特股份有限公司 |
芳基取代的嘧啶及其用途
|
DE10211555A1
(de)
|
2002-03-15 |
2003-10-02 |
Imtm Inst Fuer Medizintechnolo |
Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention dermatologischer Erkrankungen mit sebozytärer Hyperproliferation und veränderten Differenzierungszuständen
|
AR039090A1
(es)
|
2002-03-22 |
2005-02-09 |
Novartis Ag |
Combinacion de compuestos organicos
|
JP2005526811A
(ja)
|
2002-03-25 |
2005-09-08 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病の治療または予防用β−アミノ複素環式ジペプチジルペプチダーゼ阻害剤
|
WO2003080633A1
(en)
|
2002-03-25 |
2003-10-02 |
Nippon Kayaku Kabushiki Kaisha |
Novel $g(a)-amino-n-(diaminophosphinyl)lactam derivative
|
US20030232761A1
(en)
|
2002-03-28 |
2003-12-18 |
Hinke Simon A. |
Novel analogues of glucose-dependent insulinotropic polypeptide
|
TWI324064B
(en)
|
2002-04-03 |
2010-05-01 |
Novartis Ag |
Indolylmaleimide derivatives
|
CN1633420A
(zh)
|
2002-04-08 |
2005-06-29 |
托伦脱药品有限公司 |
噻唑烷-4-腈和类似物以及它们作为二肽基-肽酶抑制剂的用途
|
US20040106802A1
(en)
|
2002-04-08 |
2004-06-03 |
Torrent Pharmaceuticals Ltd. |
Novel compounds and therapeutic uses thereof
|
CA2484551A1
(en)
|
2002-04-30 |
2003-11-13 |
Trustees Of Tufts College |
Smart pro-drugs of serine protease inhibitors
|
TW200307667A
(en)
*
|
2002-05-06 |
2003-12-16 |
Bristol Myers Squibb Co |
Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
|
US7057046B2
(en)
*
|
2002-05-20 |
2006-06-06 |
Bristol-Myers Squibb Company |
Lactam glycogen phosphorylase inhibitors and method of use
|
TW200407143A
(en)
|
2002-05-21 |
2004-05-16 |
Bristol Myers Squibb Co |
Pyrrolotriazinone compounds and their use to treat diseases
|
US7858631B2
(en)
|
2002-05-23 |
2010-12-28 |
Novartis Vaccines And Diagnostics, Inc. |
Substituted pyrido [2,3-d] pyrimidinone compounds
|
GB0212412D0
(en)
|
2002-05-29 |
2002-07-10 |
Novartis Ag |
Combination of organic compounds
|
US6710040B1
(en)
*
|
2002-06-04 |
2004-03-23 |
Pfizer Inc. |
Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors
|
AU2003232405A1
(en)
|
2002-06-04 |
2003-12-19 |
Pfizer Products Inc. |
Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
|
AU2003233010A1
(en)
*
|
2002-06-04 |
2003-12-19 |
Pfizer Products Inc. |
Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
|
CA2485641C
(en)
|
2002-06-06 |
2010-12-14 |
Eisai Co., Ltd. |
Novel condensed imidazole derivatives
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
PL374963A1
(en)
|
2002-06-17 |
2005-11-14 |
Smithkline Beecham Corporation |
Chemical process
|
US20040009972A1
(en)
*
|
2002-06-17 |
2004-01-15 |
Ding Charles Z. |
Benzodiazepine inhibitors of mitochondial F1F0 ATP hydrolase and methods of inhibiting F1F0 ATP hydrolase
|
SE0201976D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
US20040006004A1
(en)
|
2002-06-27 |
2004-01-08 |
Markku Koulu |
Method for prevention and treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
US20040054171A1
(en)
*
|
2002-07-04 |
2004-03-18 |
Jensen Anette Frost |
Polymorphic forms of a 4H-thieno[3,2-E]-1,2,4-thiadiazine 1,1-dioxide derivative
|
PL374860A1
(en)
|
2002-07-09 |
2005-11-14 |
Bristol-Myers Squibb Company |
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
|
NZ537251A
(en)
|
2002-07-09 |
2007-02-23 |
Bristol Myers Squibb Co |
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
|
EP1578362A4
(de)
|
2002-07-09 |
2008-11-05 |
Point Therapeutics Inc |
Kombinationstherapie mit einer boroprolin-verbindung
|
JPWO2004007446A1
(ja)
|
2002-07-10 |
2005-11-10 |
アステラス製薬株式会社 |
新規なアゼチジン誘導体又はその塩
|
CA2490818A1
(en)
|
2002-07-15 |
2004-01-22 |
Merck & Co., Inc. |
Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
|
JP2004099600A
(ja)
|
2002-07-19 |
2004-04-02 |
Sankyo Co Ltd |
二環性アミノ基置換化合物を含有する医薬組成物
|
US7498157B2
(en)
|
2002-07-29 |
2009-03-03 |
Mitsubishi Tanabe Pharma Corporation |
Three-dimensional structure of dipeptidyl peptidase IV
|
DE60322224D1
(de)
|
2002-08-08 |
2008-08-28 |
Takeda Pharmaceutical |
Kondensierte heterozyklische verbindungen als petidase inhibitoren
|
ES2306781T3
(es)
|
2002-08-09 |
2008-11-16 |
Prosidion Ltd. |
Inhibidores de la dipeptidil-peptidasa iv para disminucion de la tasa de aumento cronico de peso.
|
EA016166B1
(ru)
|
2002-08-21 |
2012-02-28 |
Бёрингер Ингельхайм Фарма Гмбх & Ко. Кг |
8-[3-аминопиперидин-1-ил]ксантины, способ их получения и их применение в качестве лекарственных средств
|
US7407955B2
(en)
*
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US7495005B2
(en)
|
2002-08-22 |
2009-02-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, their preparation and their use in pharmaceutical compositions
|
DE10238477A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Purinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
DE10238470A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
EA007613B1
(ru)
|
2002-08-29 |
2006-12-29 |
Тайсо Фармасьютикал Ко., Лтд. |
Бензолсульфонатная соль (2s,4s)-1-циано-4-фтор-1-[(2-гидрокси-1,1-диметил)этиламино]ацетилпирролидина
|
US6998502B1
(en)
|
2002-09-05 |
2006-02-14 |
Sabinsa Corporation |
Convenient process of manufacture for difluoromethylornithine and related compounds
|
EP1398032A1
(de)
|
2002-09-10 |
2004-03-17 |
PheneX Pharmaceuticals AG |
4-Oxochinazoline, die an den LXR Kernrezeptor binden
|
AU2003262059A1
(en)
|
2002-09-11 |
2004-04-30 |
Takeda Pharmaceutical Company Limited |
Sustained release preparation
|
JP2004123738A
(ja)
|
2002-09-11 |
2004-04-22 |
Takeda Chem Ind Ltd |
徐放性製剤
|
WO2004031374A2
(en)
|
2002-09-18 |
2004-04-15 |
Prosidion Ltd. |
Secondary binding site of dipeptidyl peptidase iv (dp iv)
|
US20040058876A1
(en)
*
|
2002-09-18 |
2004-03-25 |
Torsten Hoffmann |
Secondary binding site of dipeptidyl peptidase IV (DP IV)
|
US7262207B2
(en)
|
2002-09-19 |
2007-08-28 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
ATE368647T1
(de)
|
2002-09-19 |
2007-08-15 |
Abbott Lab |
Pharmazeutische zusammensetzung und ihre verwendung als inhibitoren von der dipeptidyl peptidase iv (dpp-iv)
|
RU2328280C2
(ru)
|
2002-09-26 |
2008-07-10 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Комбинационное лекарство
|
US6869966B2
(en)
|
2002-09-30 |
2005-03-22 |
Banyu Pharmaceutical Co., Ltd. |
N-substituted-2-oxodihydropyridine derivatives
|
DE60315687T2
(de)
|
2002-10-07 |
2008-06-05 |
Merck & Co., Inc. |
Antidiabetische heterocyclische beta-aminoverbindungen als inhibitoren von dipeptidylpeptidase
|
WO2004033455A2
(en)
|
2002-10-08 |
2004-04-22 |
Novo Nordisk A/S |
Hemisuccinate salts of heterocyclic dpp-iv inhibitors
|
AU2003282510A1
(en)
|
2002-10-11 |
2004-05-04 |
Bristol-Myers Squibb Company |
Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
|
NZ538897A
(en)
|
2002-10-18 |
2007-02-23 |
Merck & Co Inc |
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
US20040132732A1
(en)
|
2002-10-21 |
2004-07-08 |
Wei Han |
Quinazolinones and derivatives thereof as factor Xa inhibitors
|
AU2003282983A1
(en)
|
2002-10-23 |
2004-05-13 |
Bristol-Myers Squibb Company |
Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods
|
AU2003286776A1
(en)
|
2002-10-30 |
2004-06-07 |
Guilford Pharmaceuticals Inc. |
Novel inhibitors of dipeptidyl peptidase iv
|
DE60310991T2
(de)
|
2002-11-07 |
2007-10-18 |
Merck & Co, Inc. |
Phenylalaninderivate als hemmer der dipeptidyl peptidase zur behandlung oder prävention von diabetes
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
JP2006508975A
(ja)
|
2002-11-18 |
2006-03-16 |
ファイザー・プロダクツ・インク |
ジペプチジルペプチダーゼivを阻害するフッ素化環状アミド
|
DE10254304A1
(de)
|
2002-11-21 |
2004-06-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
AU2002952946A0
(en)
|
2002-11-27 |
2002-12-12 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
US7109192B2
(en)
*
|
2002-12-03 |
2006-09-19 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
|
DE10256264A1
(de)
|
2002-12-03 |
2004-06-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue substituierte Imidazo-pyridinone und Imidazo-pyridazinone, ihre Herstellung und ihre Verwendung als Arzneimittel
|
AU2003302657B8
(en)
|
2002-12-04 |
2009-12-03 |
Eisai R&D Management Co., Ltd. |
Fused 1,3-dihydroimidazole ring compounds
|
CA2508487A1
(en)
|
2002-12-04 |
2004-06-17 |
Merck & Co., Inc. |
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
US7420079B2
(en)
|
2002-12-09 |
2008-09-02 |
Bristol-Myers Squibb Company |
Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
|
US20060052382A1
(en)
|
2002-12-20 |
2006-03-09 |
Duffy Joseph L |
3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
US7135467B2
(en)
|
2003-01-13 |
2006-11-14 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
CA2512546A1
(en)
|
2003-01-17 |
2004-08-05 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
AU2004210149A1
(en)
|
2003-01-31 |
2004-08-19 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
EP1595866B1
(de)
|
2003-01-31 |
2016-06-08 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
Zur Behandlung von unter anderem metabolischem Syndrom geeignete Cyanopyrryolidine
|
WO2004071454A2
(en)
|
2003-02-13 |
2004-08-26 |
Guilford Pharmaceuticals Inc. |
Substituted azetidine compounds as inhibitors of dipeptidyl peptidase iv
|
DE10308356A1
(de)
|
2003-02-27 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
|
DE10308351A1
(de)
|
2003-02-27 |
2004-11-25 |
Aventis Pharma Deutschland Gmbh |
1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US7148246B2
(en)
|
2003-02-27 |
2006-12-12 |
Sanofi-Aventis Deutschland Gmbh |
Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
|
DE10308353A1
(de)
|
2003-02-27 |
2004-12-02 |
Aventis Pharma Deutschland Gmbh |
Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2004076434A1
(en)
|
2003-02-28 |
2004-09-10 |
Aic |
Dipeptidyl peptidase inhibitors
|
AU2003207881A1
(en)
|
2003-02-28 |
2004-09-17 |
Aic |
Dipeptidyl peptidase inhibitors
|
WO2004078777A2
(en)
|
2003-03-04 |
2004-09-16 |
Biorexis Pharmaceutical Corporation |
Dipeptidyl-peptidase protected proteins
|
AR043443A1
(es)
|
2003-03-07 |
2005-07-27 |
Merck & Co Inc |
Procedimiento de preparacion de tetrahidrotriazolopirazinas y productos intermedios
|
US20050014732A1
(en)
|
2003-03-14 |
2005-01-20 |
Pharmacia Corporation |
Combination of an aldosterone receptor antagonist and an anti-diabetic agent
|
AR043505A1
(es)
|
2003-03-18 |
2005-08-03 |
Merck & Co Inc |
Preparacion de beta-cetoamidas e intermediarios de reaccion
|
WO2004085661A2
(en)
|
2003-03-24 |
2004-10-07 |
Merck & Co., Inc |
Process to chiral beta-amino acid derivatives
|
US7550590B2
(en)
|
2003-03-25 |
2009-06-23 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
TWI357408B
(en)
|
2003-03-26 |
2012-02-01 |
Mitsubishi Tanabe Pharma Corp |
3-substituted-4-pyrimidone derivatives
|
WO2004087880A2
(en)
|
2003-03-26 |
2004-10-14 |
Bayer Pharmaceuticals Corporation |
Compounds and their use to treat diabetes and related disorders
|
WO2004087650A2
(en)
|
2003-03-27 |
2004-10-14 |
Merck & Co. Inc. |
Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-iv inhibitors
|
WO2004089362A1
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
2-cyanopyrroles and their analogues as ddp-iv inhibitors
|
WO2004096806A1
(ja)
|
2003-04-30 |
2004-11-11 |
Sumitomo Pharmaceuticals Co. Ltd. |
縮合イミダゾール誘導体
|
WO2004098625A2
(en)
|
2003-05-05 |
2004-11-18 |
Probiodrug Ag |
Medical use of inhibitors of glutaminyl and glutamate cyclases
|
EP1961416B1
(de)
*
|
2003-05-05 |
2013-01-23 |
Probiodrug AG |
Verwendung von Hemmern von Glutaminylcyclase zur Behandlung von Rheumatoider Arthritis, Psoriasis oder Atherosklerose
|
US20040229848A1
(en)
|
2003-05-05 |
2004-11-18 |
Hans-Ulrich Demuth |
Glutaminyl based DP IV-inhibitors
|
US7371871B2
(en)
|
2003-05-05 |
2008-05-13 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
AU2003902260A0
(en)
|
2003-05-09 |
2003-05-29 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
WO2004103276A2
(en)
|
2003-05-14 |
2004-12-02 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
JP2007511467A
(ja)
|
2003-05-14 |
2007-05-10 |
タケダ サン ディエゴ インコーポレイテッド |
ジペプチジルペプチダーゼインヒビター
|
CN1791575A
(zh)
|
2003-05-15 |
2006-06-21 |
大正制药株式会社 |
氰基氟代吡咯烷
|
EP1631679A2
(de)
|
2003-05-21 |
2006-03-08 |
Bayer HealthCare AG |
Diagnostika und therapeutika, die mit der dipeptidylpeptidase 7 (dpp7) assoziiert sind
|
WO2004104216A2
(en)
|
2003-05-21 |
2004-12-02 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4)
|
CA2526770A1
(en)
|
2003-06-06 |
2004-12-23 |
Merck & Co., Inc. |
Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
AU2003902946A0
(en)
|
2003-06-12 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
WO2004112701A2
(en)
|
2003-06-17 |
2004-12-29 |
Merck & Co., Inc. |
Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
DE10327439A1
(de)
|
2003-06-18 |
2005-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazopyridazinon- und Imidazopyridonderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
US7566707B2
(en)
*
|
2003-06-18 |
2009-07-28 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
|
CN101090901B
(zh)
|
2003-06-20 |
2010-12-15 |
霍夫曼-拉罗奇有限公司 |
作为dpp-iv抑制剂的六氢吡啶并异喹啉类
|
EP1638970B1
(de)
|
2003-06-20 |
2010-11-24 |
F. Hoffmann-La Roche AG |
Pyrido[2,1-a]-isochinolinderivate als dpp-iv inhibitoren
|
JO2625B1
(en)
*
|
2003-06-24 |
2011-11-01 |
ميرك شارب اند دوم كوربوريشن |
Phosphoric acid salts of dipeptidyl betidase inhibitor 4
|
DE10330842A1
(de)
|
2003-07-08 |
2005-02-10 |
Institut für Medizintechnologie Magdeburg GmbH, IMTM |
Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention dermatologischer Erkrankungen mit Hyperproliferation und veränderten Differenzierungszuständen von Fibroblasten
|
US7259160B2
(en)
|
2003-07-31 |
2007-08-21 |
Merck & Co., Inc. |
Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
US6995183B2
(en)
*
|
2003-08-01 |
2006-02-07 |
Bristol Myers Squibb Company |
Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
|
US7470700B2
(en)
|
2003-08-13 |
2008-12-30 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
WO2005019168A2
(en)
*
|
2003-08-20 |
2005-03-03 |
Pfizer Products Inc. |
Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
|
JP2007513058A
(ja)
|
2003-09-08 |
2007-05-24 |
武田薬品工業株式会社 |
ジペプチジルぺプチダーゼ阻害剤
|
EP1699777B1
(de)
|
2003-09-08 |
2012-12-12 |
Takeda Pharmaceutical Company Limited |
Dipeptidylpeptidase-hemmer
|
BRPI0507485A
(pt)
|
2004-02-05 |
2007-07-10 |
Probiodrug Ag |
inibidores novos de glutaminil ciclase
|
NZ549716A
(en)
|
2004-03-15 |
2010-04-30 |
Takeda Pharmaceutical |
Pyrimidin-dione derivatives as dipeptidyl peptidase inhibitors
|
EP1778236B1
(de)
|
2004-07-02 |
2010-07-14 |
Corcept Therapeutics, Inc. |
Modifizierte pyrimidin-glucocorticoid-rezeptor-modulatoren
|
EP1828192B1
(de)
|
2004-12-21 |
2014-12-03 |
Takeda Pharmaceutical Company Limited |
Dipeptidylpeptidasehemmer
|
US20070060529A1
(en)
|
2005-09-14 |
2007-03-15 |
Christopher Ronald J |
Administration of dipeptidyl peptidase inhibitors
|
CN102940638B
(zh)
|
2005-09-14 |
2015-03-04 |
武田药品工业株式会社 |
用于治疗糖尿病的二肽基肽酶抑制剂
|
PE20070522A1
(es)
|
2005-09-14 |
2007-07-11 |
Takeda Pharmaceutical |
2-[6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-pirimidin-1-ilmetil]-4-fluoro-benzonitrilo como inhibidor de dipeptidil peptidasa y composiciones farmaceuticas que lo contienen
|
TW200745079A
(en)
|
2005-09-16 |
2007-12-16 |
Takeda Pharmaceuticals Co |
Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
|